Canlyniadau Chwilio - Ceccherini‐Silberstein, Francesca

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors) gan Ceccherini-Silberstein, Francesca

Cael y testun llawn Cael y testun llawn

Selected amino acid mutations in HIV-1 B subtype gp41 are Associated with Specific gp120(V3 )signatures in the regulation of Co-Receptor usage gan Dimonte, Salvatore, Mercurio, Fabio, Svicher, Valentina, D'Arrigo, Roberta, Perno, Carlo-Federico, Ceccherini-Silberstein, Francesca

Cael y testun llawn Cael y testun llawn Cael y testun llawn

HIV-Infected Late Presenter Patients gan D'Arminio Monforte, Antonella, Antinori, Andrea, Girardi, Enrico, Ceccherini-Silberstein, Francesca, Marchetti, Giulia, Sabin, Caroline Anne, Montaner, Julio S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C gan Popping, Stephanie, Cento, Valeria, García, Federico, Ceccherini-Silberstein, Francesca, Seguin-Devaux, Carole, Vijver, David AMC, Boucher, Charles A

Cael y testun llawn Cael y testun llawn

Identification of a novel Rev-interacting cellular protein gan Kramer-Hämmerle, Susanne, Ceccherini-Silberstein, Francesca, Bickel, Christian, Wolff, Horst, Vincendeau, Michelle, Werner, Thomas, Erfle, Volker, Brack-Werner, Ruth

Cael y testun llawn Cael y testun llawn Cael y testun llawn

2019 Update of the Drug Resistance Mutations in HIV-1 gan Wensing, Annemarie M., Calvez, Vincent, Ceccherini-Silberstein, Francesca, Charpentier, Charlotte, Günthard, Huldrych F., Paredes, Roger, Shafer, Robert W., Richman, Douglas D.

Cael y testun llawn Cael y testun llawn

Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003–2012 decade in Italy gan Franzetti, Marco, Violin, Michela, Antinori, Andrea, De Luca, Andrea, Ceccherini-Silberstein, Francesca, Gianotti, Nicola, Torti, Carlo, Bonora, Stefano, Zazzi, Maurizio, Balotta, Claudia

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Short Communication: Characterization of Drug-Resistance Mutations in HIV Type 1 Isolates from Drug-Naive and ARV-Treated Patients in Bulgaria gan Santoro, Maria Mercedes, Ciccozzi, Massimo, Alteri, Claudia, Montieri, Stefania, Alexiev, Ivailo, Dimova, Iordanka, Ceccherini-Silberstein, Francesca, Beshkov, Danail, Rezza, Giovanni, Perno, Carlo Federico

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility gan Puertas, Maria Carmen, Buzón, Maria Jose, Artese, Anna, Alcaro, Stefano, Menendez-Arias, Luis, Perno, Carlo Federico, Clotet, Bonaventura, Ceccherini-Silberstein, Francesca, Martinez-Picado, Javier

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage gan Borrajo, Ana, Ranazzi, Alessandro, Pollicita, Michela, Bellocchi, Maria Concetta, Salpini, Romina, Mauro, Maria Vittoria, Ceccherini-Silberstein, Francesca, Perno, Carlo Federico, Svicher, Valentina, Aquaro, Stefano

Cael y testun llawn Cael y testun llawn Cael y testun llawn

First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing... gan Alkhatib, Mohammad, Bellocchi, Maria Concetta, Marchegiani, Greta, Grelli, Sandro, Micheli, Valeria, Stella, Daniele, Zerillo, Bartolomeo, Carioti, Luca, Svicher, Valentina, Rogliani, Paola, Ceccherini-Silberstein, Francesca

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study gan Marchetti, Giulia, Cozzi-Lepri, Alessandro, Tincati, Camilla, Calcagno, Andrea, Ceccherini-Silberstein, Francesca, De Luca, Andrea, Antinori, Andrea, Castagna, Antonella, Puoti, Massimo, Monforte, Antonella d’Arminio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors gan Svicher, Valentina, Ceccherini-Silberstein, Francesca, Erba, Fulvio, Santoro, Maria, Gori, Caterina, Bellocchi, Maria Concetta, Giannella, Sara, Trotta, Maria Paola, Monforte, Antonella d'Arminio, Antinori, Andrea, Perno, Carlo Federico

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Inhibition of Dual/Mixed Tropic HIV-1 Isolates by CCR5-Inhibitors in Primary Lymphocytes and Macrophages gan Surdo, Matteo, Balestra, Emanuela, Saccomandi, Patrizia, Di Santo, Fabiola, Montano, Marco, Di Carlo, Domenico, Sarmati, Loredana, Aquaro, Stefano, Andreoni, Massimo, Svicher, Valentina, Perno, Carlo Federico, Ceccherini-Silberstein, Francesca

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district gan Polilli, Ennio, Cento, Valeria, Restelli, Umberto, Ceccherini-Silberstein, Francesca, Aragri, Marianna, Di Maio, Velia Chiara, Sciacca, Antonina, Santoleri, Fiorenzo, Fazii, Paolo, Costantini, Alberto, Perno, Carlo Federico, Parruti, Giustino

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses gan Artese, Anna, Svicher, Valentina, Costa, Giosuè, Salpini, Romina, Di Maio, Velia Chiara, Alkhatib, Mohammad, Ambrosio, Francesca Alessandra, Santoro, Maria Mercedes, Assaraf, Yehuda G., Alcaro, Stefano, Ceccherini-Silberstein, Francesca

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy gan Fabeni, Lavinia, Santoro, Maria Mercedes, Lorenzini, Patrizia, Rusconi, Stefano, Gianotti, Nicola, Costantini, Andrea, Sarmati, Loredana, Antinori, Andrea, Ceccherini-Silberstein, Francesca, d’Arminio Monforte, Antonella, Saracino, Annalisa, Girardi, Enrico

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Description of the L76V Resistance Protease Mutation in HIV-1 B and “Non-B” Subtypes gan Charpentier, Charlotte, Lambert-Niclot, Sidonie, Alteri, Claudia, Storto, Alexandre, Flandre, Philippe, Svicher, Valentina, Perno, Carlo-Federico, Brun-Vézinet, Françoise, Calvez, Vincent, Marcelin, Anne-Geneviève, Ceccherini-Silberstein, Francesca, Descamps, Diane

Cael y testun llawn Cael y testun llawn Cael y testun llawn

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients gan Saracino, Annalisa, Cozzi-Lepri, Alessandro, Shanyinde, Milensu, Ceccherini Silberstein, Francesca, Nozza, Silvia, Di Biagio, Antonio, Cassola, Giovanni, Bruno, Giuseppe, Capobianchi, Maria, Puoti, Massimo, Monno, Laura, d’Arminio Monforte, Antonella

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort gan Mondi, Annalisa, Cozzi‐Lepri, Alessandro, Tavelli, Alessandro, Rusconi, Stefano, Vichi, Francesca, Ceccherini‐Silberstein, Francesca, Calcagno, Andrea, De Luca, Andrea, Maggiolo, Franco, Marchetti, Giulia, Antinori, Andrea, d'Arminio Monforte, Antonella

Cael y testun llawn Cael y testun llawn Cael y testun llawn